Our study proposed that the combined biomarkers of serum TSLP and tryptase levels, and blood eosinophil count may be linked to distinct inflammatory mechanisms in asthma and be useful to predict the future risk of asthma exacerbation. This evidence concerns the gene TSLP and asthma.